Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹1,258.90
Market cap: ₹17,466 Cr
Revenue (annual): ₹3,129 Cr
Net profit (annual): ₹619.5 Cr
P/E (TTM): 27.1×Sector 50.4×
Promoter holding: 54.14%+0.22% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Management Change 2 Financial Results 2 Annual General Meeting 2 Price Movement Clarification 1 Employee Stock Options 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

21 Sep 2026 09:09 IST NSE

Management Change

Eris Lifesciences Management Change

Eris Lifesciences appointed Mr. Akhil Awasthi as Non-Executive Independent Director effective September 26, 2026 for a five-year term, subject to shareholder approval. No monetary value is associated with the appointment.

Read the filing ↗

11 Sep 2026 16:09 IST NSE

Management Change

Eris Lifesciences Management Change

Mr. Krishnakumar Vaidyanathan has resigned as Executive Director and Chief Operating Officer of Eris Lifesciences Limited, effective September 30, 2026.

Read the filing ↗